Cite
Lopinavir/ritonavir plus lamivudine and abacavir or zidovudine dose ratios for paediatric fixed-dose combinations
MLA
Bouazza, N., et al. “Lopinavir/Ritonavir plus Lamivudine and Abacavir or Zidovudine Dose Ratios for Paediatric Fixed-Dose Combinations.” Antiviral Therapy, 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284126156&authtype=sso&custid=ns315887.
APA
Bouazza, N., Foissac, F., Fauchet, F., Burger, D. M., Kiechel, J. R., Treluyer, J. M., Capparelli, E. V., Lallemant, M., & Urien, S. (2015). Lopinavir/ritonavir plus lamivudine and abacavir or zidovudine dose ratios for paediatric fixed-dose combinations. Antiviral Therapy.
Chicago
Bouazza, N., F. Foissac, F. Fauchet, D.M. Burger, J.R. Kiechel, J.M. Treluyer, E.V. Capparelli, M. Lallemant, and S. Urien. 2015. “Lopinavir/Ritonavir plus Lamivudine and Abacavir or Zidovudine Dose Ratios for Paediatric Fixed-Dose Combinations.” Antiviral Therapy. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284126156&authtype=sso&custid=ns315887.